Our flagship product launches in 2026,
targeting a global multi-billion-dollar market.

IG’s patented (ECM) process utilizes the placenta’s natural healing elements—like growth factors and structural proteins—to help the body repair itself. They provide a supportive scaffold that encourages new skin growth, reduces inflammation, and limits scarring. This leads to faster wound closure and stronger, longer-lasting healing.